About Aspiro Pharma
Aspiro Pharma is a Healthcare company based in Hyderabad (India). Research, development, and manufacturing of pharmaceutical formulations in India. It operates in the Healthcare and Agriculture sectors. The company has 408 employees. Its Indian entity Aspiro Pharma Limited reported revenue of ₹418 Cr. Aspiro Pharma offers products and services including General Parenteral Formulations and R&D Services. Its focus areas include Pharmaceuticals, Drug Manufacturing, Parenteral Formulations and Research and Development.
Company details
Aspiro is identified as a fast-growing pharmaceutical company in India that is fully committed to the research, development, and manufacturing of general parenteral formulations. Its manufacturing facilities have been certified with GMP approvals from various international bodies, including those in Ukraine, Brazil, UAE, and Colombia. The in-house RD unit is recognized by the Department of Scientific and Industrial Research, and contributions to global health, such as in the fight against Covid-19, are noted. Operations are based in Telangana, India, with a focus on advancing affordable healthcare through technological innovations and partnerships.
- Headquarters Hyderabad, India
- Employees 408
- SectorsHealthcareAgriculture
- Email••••••••
- Website aspiropharma.com
- Legal Name Aspiro Pharma Limited
- Date of Incorporation 05 Feb, 2014
- Jurisdiction Markook, Telangana, India
- Annual Revenue₹418 Cr
FY 2025 · +147% YoY
- Net Profit₹25.39 Cr
FY 2025 · 6% margin
- EBITDA₹84.99 Cr
FY 2025 · 20% margin
- Employee Count408
Associated legal entities of Aspiro Pharma
Aspiro Pharma operates through Aspiro Pharma Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Aspiro Pharma Limited CIN U24100TG2014PLC092771 | Active | 05 Feb 2014 | Markook, Telangana | ₹418 Cr | 408 | 9 | View details |
Products & Services of Aspiro Pharma
Aspiro Pharma offers a comprehensive portfolio of products and services, including General Parenteral Formulations and R&D Services.
Research, development, and manufacturing of injectable medicines are undertaken by the company.
In-house research and development activities are conducted to support scientific advancements.
Board of directors of Aspiro Pharma Limited (Aspiro Pharma)
Aspiro Pharma Limited is the primary company behind Aspiro Pharma. The board of Aspiro Pharma Limited currently have 6 directors; the longest-serving is Bandi Vamsikrishna, appointed in 2014. 16 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Bandi Vamsikrishna DIN 01014619 | Director | 13 Feb 2014 | 12 yrs 8 mo | Aspiro Pharma Limited |
| Krishnaveni Kura DIN 07033330 | Director | 29 Jun 2017 | 9 yrs 4 mo | Aspiro Pharma Limited |
| Mahesh Ramappa Kamalamma Hassan DIN 08099535 | Director | 07 Jun 2023 | 3 yrs 4 mo | Aspiro Pharma Limited |
| Ramaseshappa Siva Prasad Panchangam DIN 09447160 | Director | 03 Aug 2023 | 3 yrs 2 mo | Aspiro Pharma Limited |
| Reddy Narsimha DIN 07850148 | Director | 03 Aug 2024 | 2 yrs 2 mo | Aspiro Pharma Limited |
| Bhaskarreddy Pabbatireddy DIN 07347185 | Additional Director | 10 Oct 2025 | 1 yr | Aspiro Pharma Limited |
Financials of Aspiro Pharma
Figures of Aspiro Pharma Limited, the primary company behind Aspiro Pharma, for FY 2025. Revenue was ₹418 Cr (+147% year on year). Net profit was ₹25.39 Cr (6% margin). EBITDA was ₹84.99 Cr (20% margin). Revenue has grown at a compounded annual rate of +67% over three years and +80% over five years.
- ₹418 CrRevenue · FY 2025 · +147% YoY
- ₹25.39 CrNet profit · 6% margin
- ₹84.99 CrEBITDA · 20% margin
- ₹1,004 CrPaid-up capital
- 408Employees (provident fund records)
- +67%Revenue CAGR, 3 years
- +80%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Aspiro Pharma Limited are on its company page.
Detailed financial statements for Aspiro Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Aspiro Pharma
The website of Aspiro Pharma (aspiropharma.com) receives about 1.6K visits a month.
- Monthly visits1.6K
▲ 14.6% vs previous month
Websites whose visitors overlap most with Aspiro Pharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| letsaspiro.com | 100% | 1.4K | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Aspiro Pharma
Aspiro Pharma is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Aspiro Pharma has 408 employees.
The primary company behind Aspiro Pharma, Aspiro Pharma Limited, reported revenue of ₹418 Cr for FY 2025, up 147% year on year.
Aspiro is identified as a fast-growing pharmaceutical company in India that is fully committed to the research, development, and manufacturing of general parenteral formulations. Its manufacturing facilities have been certified with GMP approvals from various international bodies, including those in Ukraine, Brazil, UAE, and Colombia. The in-house RD unit is recognized by the Department of Scientific and Industrial Research, and contributions to global health, such as in the fight against Covid-19, are noted. Operations are based in Telangana, India, with a focus on advancing affordable healthcare through technological innovations and partnerships.
Aspiro Pharma offers General Parenteral Formulations and R&D Services.
Aspiro Pharma operates through Aspiro Pharma Limited.
The legal entities of Aspiro Pharma currently have 9 directors, including Bandi Vamsikrishna, Reddy Narsimha, Srinivas Dakarapu and others.